SYDNEY, Nov. 19, 2025 -- Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an FDA-authorized single-patient expanded access protocol combining paxalisib with pembrolizumab (Keytruda®) and standard chemotherapy has achieved an initial immune-complete response (iCR) per iRECIST criteria. This outcome suggests a profound radiologic response in a highly aggressive metastatic cancer subtype. This development builds upon Kazia's October 2, 2025 announceme
BEIJING, Nov. 18, 2025 -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company") ,a Nevada-based high-tech enterprise engaged in acoustic technologies and AI multimodal digitalization, today issues a brief statement regarding recent trading activity in its common stock. The Company has observed fluctuations in its share price and trading volume over the past several days. Datasea emphasizes that operations remain normal, the Company's business and financial position are solid, and all core initiatives continue to progress as planned. Management is not aware of any
이번 수상으로 아지노모토 바이오파마 서비스의 혁신과 과학적 우수성이 차세대 항체-약물 접합체 기술 발전에 이바지하고 있음이 입증되었다 도쿄, 2025년 11월 18일 -- 생물약제 위탁 개발 및 제조 서비스 분야를 선도하는 아지노모토 바이오파마 서비스(Ajinomoto Bio-Pharma Services, 이하 '아지 바이오파마')가 오늘 AJICAP® 링커 기술을 다룬 자사의 혁신적인 연구 논문이 제12회 월드 ADC 어워드(World ADC Awards)에서 '2024년 최우수 ADC 전임상 논문(Best ADC Preclinical Publication 2024)' 수상작으로 선정되었다고 전했다. 의약화학 저널(Journal of Medicinal Chemistry)에 게재된 수상 논문 '외부 절단 방식 링커: 항체-약물 접합체의 안정성과 치료 효과 개선(Exo-Cleavable Linkers: Enhanced Stability and Therapeutic Efficacy in Antibody–Drug Conjugates)에는 아지 바이오파마의 AJICAP® 위치 특이적 접합 및 링커 기술에 대한
HEFEI, China, Nov. 18, 2025 -- Kangpu Biopharmaceuticals announced today that the company will deliver a poster presentation to highlight the Phase I clinical trial results of epaldeudomide (KPG-818) for the treatment of hematological malignancies at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, Florida, USA. Poster Title: KPG-818, a Novel Cereblon (CRBN) Modulator, in Patients with Hematological Malignancies: Results of a Phase I, Open-Label, Multiple Ascending Dose Study Poster Number: 5809 
[ 메디채널 김갑성 기자 ] Dedicated to Nurturing a New Generation of DoctorsSupporting Hong Kong Become a Hub for Medical Innovation HONG KONG, Nov. 18, 2025 -- The establishment of Hong Kong's third medical school at The Hong Kong University of Science and Technology (HKUST) was approved today by the Hong Kong SAR Government (the Government). This landmark decision underscores the visionary leadership of the Government in fortifying Hong Kong's medical system. The University expresses its deepest gratitude to the Hong Kong SAR Government for its trust and to the dedicated Task Group on
GUIYANG, China, Nov. 18, 2025 -- Tuyunguan Pass in Guizhou province, one of the capital city Guiyang's important pass – "nine gates, four pavilions, and fourteen passes" – was stationed by thousands of Chinese and international medical workers of the Chinese Red Cross Medical Relief Corps during the World Anti-Fascist War. Regardless of the danger to their lives, the medical workers bravely went to battle zones to save lives, and some of them were killed in battle, making remarkable contributions to the victory of the World Anti-Fascist War. This year marks
KUALA LUMPUR, Malaysia, Nov. 18, 2025 -- Vantage Foundation continued its mission to drive meaningful community impact through a recent collaboration with Kechara Soup Kitchen (KSK), one of Malaysia's leading non-governmental organisations dedicated to serving the urban, rural poor, Orang Asli and houseless communities for more than 17 years. KSK operates through a multi-pronged approach; comprising its Food Bank, Empowerment programmes, and Soup Kitchen; guided by the motto "Hunger Knows No Barriers". The volunteer activity took place at the Kechara Food Bank in Setapak, a
HONG KONG, Nov. 18, 2025 -- The Society for the Relief of Disabled Children (SRDC), one of Hong Kong's longest-standing non-profit organisations, is proud to announce the 42nd Sandy Bay Charity Fair at The Duchess of Kent Children's Hospital (DKCH). The event has taken place on Saturday, 15th November 2025, from 10:00 am to 5:00 pm. Photo Download: https://shorturl.at/KgtlF This year's fair is particularly special as it coincided with the 70th anniversary of SRDC, the founding organisation of DKCH. SRDC formed and built HK's first convalescent home for children with dis
SYDNEY, Nov. 18, 2025 -- HealthScreen has officially opened its new Sydney facility, expanding the organisation's preventative health and executive services following strong demand at its flagship Melbourne centre. The new location brings together advanced multi-modal imaging, genetics, biomarker analysis and AI-enabled diagnostics to support earlier detection of disease and more personalised long-term health management. HealthScreen's one-day assessment model uses AI-assisted MRI screening sequences, genetic testing, and a diagnostic panel measuring more than 100 biomarkers ac
[ 메디채널 김갑성 기자 ] Canadian Cancer Society report highlights global progress on key tobacco control measures TORONTO, Nov. 18, 2025 -- An international report released today by the Canadian Cancer Society (CCS) reveals ongoing progress for tobacco plain packaging and graphic picture warnings worldwide. The CCS report, titled Cigarette Package Health Warnings: International Status Report, details global developments on plain packaging, ranks 212 countries and territories on the size of their health warnings on cigarette packages, and lists the 140 countries and territories that now requi